JP2018536163A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018536163A5 JP2018536163A5 JP2018526566A JP2018526566A JP2018536163A5 JP 2018536163 A5 JP2018536163 A5 JP 2018536163A5 JP 2018526566 A JP2018526566 A JP 2018526566A JP 2018526566 A JP2018526566 A JP 2018526566A JP 2018536163 A5 JP2018536163 A5 JP 2018536163A5
- Authority
- JP
- Japan
- Prior art keywords
- dye
- primary antibody
- enzyme
- tissue sample
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000523 sample Substances 0.000 claims 21
- 102000008096 B7-H1 Antigen Human genes 0.000 claims 16
- 108010074708 B7-H1 Antigen Proteins 0.000 claims 16
- 102000004190 Enzymes Human genes 0.000 claims 14
- 108090000790 Enzymes Proteins 0.000 claims 14
- 210000002865 immune cell Anatomy 0.000 claims 14
- 238000000034 method Methods 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 8
- 239000002771 cell marker Substances 0.000 claims 8
- 238000001514 detection method Methods 0.000 claims 8
- 239000003153 chemical reaction reagent Substances 0.000 claims 7
- 238000000151 deposition Methods 0.000 claims 6
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims 4
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 102000008203 CTLA-4 Antigen Human genes 0.000 claims 2
- 108010021064 CTLA-4 Antigen Proteins 0.000 claims 2
- 229940045513 CTLA4 antagonist Drugs 0.000 claims 2
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims 2
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims 2
- 101000984753 Homo sapiens Serine/threonine-protein kinase B-raf Proteins 0.000 claims 2
- 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 claims 2
- 101710120843 Indoleamine 2,3-dioxygenase 1 Proteins 0.000 claims 2
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims 2
- 102100027103 Serine/threonine-protein kinase B-raf Human genes 0.000 claims 2
- 230000008021 deposition Effects 0.000 claims 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 238000002626 targeted therapy Methods 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 239000000439 tumor marker Substances 0.000 claims 2
- -1 FoxP3 Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562258493P | 2015-11-22 | 2015-11-22 | |
| US62/258,493 | 2015-11-22 | ||
| PCT/EP2016/078237 WO2017085307A1 (en) | 2015-11-22 | 2016-11-21 | Methods of identifying immune cells in pd-l1 positive tumor tissue |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018536163A JP2018536163A (ja) | 2018-12-06 |
| JP2018536163A5 true JP2018536163A5 (cg-RX-API-DMAC10.html) | 2019-11-07 |
| JP6832930B2 JP6832930B2 (ja) | 2021-02-24 |
Family
ID=57391956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018526566A Active JP6832930B2 (ja) | 2015-11-22 | 2016-11-21 | Ｐｄ−ｌ１陽性腫瘍組織における免疫細胞を同定する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11899016B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3377530B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6832930B2 (cg-RX-API-DMAC10.html) |
| AU (1) | AU2016357478B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3005804C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2886600T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2017085307A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150131269A (ko) | 2013-03-15 | 2015-11-24 | 제넨테크, 인크. | Pd-1 및 pd-l1 관련 상태를 치료하기 위한 바이오마커 및 방법 |
| CN106604933B (zh) | 2014-07-11 | 2021-08-10 | 文塔纳医疗系统公司 | 抗pd-l1抗体及其诊断用途 |
| AU2017248830B2 (en) | 2016-04-15 | 2023-03-09 | Alpine Immune Sciences, Inc. | CD80 variant immunomodulatory proteins and uses thereof |
| EP3491013A1 (en) | 2016-07-28 | 2019-06-05 | Alpine Immune Sciences, Inc. | Cd155 variant immunomodulatory proteins and uses thereof |
| MX2019010887A (es) | 2017-03-16 | 2019-10-15 | Alpine Immune Sciences Inc | Proteinas inmunomoduladoras de cb80 variante y usos de estas. |
| WO2019241758A1 (en) | 2018-06-15 | 2019-12-19 | Alpine Immune Sciences, Inc. | Pd-1 variant immunomodulatory proteins and uses thereof |
| CN113544144A (zh) | 2018-09-19 | 2021-10-22 | 高山免疫科学股份有限公司 | 变体cd80融合蛋白和相关构建体的方法和用途 |
| EP3853610B1 (en) | 2018-09-20 | 2024-05-22 | Ventana Medical Systems, Inc. | Size-based gating to analyze flow cytometry data |
| CN112789684B (zh) | 2018-10-01 | 2025-05-09 | 文塔纳医疗系统公司 | 用于预测对pd-1轴导向疗法的应答的方法和系统 |
| EP3887547A1 (en) | 2018-11-29 | 2021-10-06 | Ventana Medical Systems, Inc. | Personalized ctdna disease monitoring via representative dna sequencing |
| CN115552248A (zh) * | 2020-05-07 | 2022-12-30 | 文塔纳医疗系统公司 | 用于评价肿瘤样品中egfr和egfr配体表达的组织化学系统和方法 |
| CN111830256A (zh) * | 2020-07-01 | 2020-10-27 | 北京基谱生物科技有限公司 | 一种石蜡切片免疫荧光多重染色试剂盒及使用方法 |
| JPWO2022059601A1 (cg-RX-API-DMAC10.html) * | 2020-09-16 | 2022-03-24 | ||
| EP4490509A1 (en) * | 2022-03-07 | 2025-01-15 | Astrazeneca AB | Method for predicting patient response to immunotherapy |
| US20250243260A1 (en) | 2022-03-07 | 2025-07-31 | Alpine Immune Sciences, Inc. | Immunomodulatory proteins of variant cd80 polypeptides, cell therapies and related methods and uses |
| JP2025526652A (ja) * | 2022-08-08 | 2025-08-15 | ヴェンタナ メディカル システムズ， インク． | デジタル化された病理スライドの定量化のためのシステムおよび方法 |
| JP2026519344A (ja) | 2023-04-13 | 2026-06-16 | ベンタナ メディカル システムズ， インコーポレイテッド | 固定固形腫瘍に対する増殖アッセイ |
| WO2025193604A1 (en) | 2024-03-11 | 2025-09-18 | Ventana Medical Systems, Inc. | Non-enzymatic dissociation of ffpe tissue and generation of single cells with intact cell surface markers |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69936841D1 (de) * | 1998-10-26 | 2007-09-27 | Ventana Med Syst Inc | Nachweis des humanen papilloma-virus mit hilfe des papanicolau-tests |
| US6544798B1 (en) | 1999-02-26 | 2003-04-08 | Ventana Medical Systems, Inc. | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
| US6195451B1 (en) * | 1999-05-13 | 2001-02-27 | Advanced Pathology Ststems, Inc. | Transformation of digital images |
| US8071322B2 (en) * | 2002-11-12 | 2011-12-06 | Epitomics, Inc. | Method for identifying differentially expressed proteins |
| US20130109019A1 (en) * | 2010-07-02 | 2013-05-02 | Adrian E. Murillo | Hapten conjugates for target detection |
| ES2678211T3 (es) * | 2012-03-27 | 2018-08-09 | Ventana Medical Systems, Inc. | Conjugados de señalización y procedimientos de uso |
| US9856320B2 (en) * | 2012-05-15 | 2018-01-02 | Bristol-Myers Squibb Company | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
| WO2014194293A1 (en) * | 2013-05-30 | 2014-12-04 | Amplimmune, Inc. | Improved methods for the selection of patients for pd-1 or b7-h4 targeted therapies, and combination therapies thereof |
| US20160215052A1 (en) * | 2013-07-24 | 2016-07-28 | Dana-Farber Cancer Institute, Inc. | Anti-galectin-1 (gal1) monoclonal antibodies and fragments thereof for neutralizing gal1 |
| US10241115B2 (en) * | 2013-12-10 | 2019-03-26 | Merck Sharp & Dohme Corp. | Immunohistochemical proximity assay for PD-1 positive cells and PD-ligand positive cells in tumor tissue |
| AU2015220750B2 (en) * | 2014-02-24 | 2020-04-16 | Ventana Medical Systems, Inc. | Quinone methide analog signal amplification |
-
2016
- 2016-11-21 CA CA3005804A patent/CA3005804C/en active Active
- 2016-11-21 AU AU2016357478A patent/AU2016357478B2/en active Active
- 2016-11-21 JP JP2018526566A patent/JP6832930B2/ja active Active
- 2016-11-21 ES ES16800915T patent/ES2886600T3/es active Active
- 2016-11-21 WO PCT/EP2016/078237 patent/WO2017085307A1/en not_active Ceased
- 2016-11-21 EP EP16800915.7A patent/EP3377530B1/en active Active
-
2018
- 2018-05-21 US US15/985,638 patent/US11899016B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Qu et al. | Innovative FO-SPR label-free strategy for detecting anti-RBD antibodies in COVID-19 patient serum and whole blood | |
| Brummelman et al. | Development, application and computational analysis of high-dimensional fluorescent antibody panels for single-cell flow cytometry | |
| Anderson et al. | Fully automated RNAscope in situ hybridization assays for formalin‐fixed paraffin‐embedded cells and tissues | |
| Wang et al. | Biosensors for the detection of Bacillus anthracis | |
| Arola et al. | Specific noncompetitive immunoassay for HT-2 mycotoxin detection | |
| JP2012510618A5 (cg-RX-API-DMAC10.html) | ||
| HRP20160461T1 (hr) | Solubilna humana st-2 antitijela i eseji | |
| JOP20220150A1 (ar) | مواد وطرق للاستهداف البيولوجي في الجسم الحي | |
| WO2012056407A8 (en) | Antibodies which bind soluble t-cell receptor ligands | |
| JP2011524537A5 (cg-RX-API-DMAC10.html) | ||
| US20170176423A1 (en) | Magnetic programmable bead enzyme-linked immunosorbent assay | |
| WO2013132347A3 (en) | Improved elisa immunoassay for calprotectin | |
| JP2018536163A (ja) | Ｐｄ−ｌ１陽性腫瘍組織における免疫細胞を同定する方法 | |
| Wu et al. | Magnetic-based enrichment of rare cells from high concentrated blood samples | |
| Andersson et al. | Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells | |
| Lin et al. | Rapid detection of hepatitis B virus in blood samples using a combination of polymerase spiral reaction with nanoparticles lateral-flow biosensor | |
| Skottrup et al. | Rapid determination of Phytophthora infestans sporangia using a surface plasmon resonance immunosensor | |
| Gulinaizhaer et al. | Detection of monkeypox virus using helicase dependent amplification and recombinase polymerase amplification combined with lateral flow test | |
| US20220049285A1 (en) | Single cell/exosome/vesicle protein profiling | |
| Salehi et al. | Circulating tumor cells as a promising tool for early detection of hepatocellular carcinoma | |
| Wei et al. | Ultrasensitive “hunter of target”: Rabbit monoclonal antibody-based competitive lateral flow immunoassay for saxitoxin | |
| Memon et al. | Biosensors for detection of airborne pathogenic fungal spores: a review | |
| CN109416356A (zh) | 使用ip-质谱法的抗体验证 | |
| JP2017026631A5 (cg-RX-API-DMAC10.html) | ||
| CN107937490A (zh) | 一种非对称pcr的试纸条检测植物病原菌的方法及试剂盒 |